“The Role of Intralesional Glucantime in Treating Cutaneous Leishmaniasis Lesions Complicated by Secondary Bacterial Infections: Research Article”, Pak Euro. J. Med & LS, vol. 8, no. 1, pp. 219–226, Mar. 2025, doi: 10.31580/pjmls.v8i1.3238.